Comparison of Pathways and Detection Strategies for Pancreatic Ductal Adenocarcinoma (PDAC) Using Genetically Engineered Mouse Model (GEMM)

File(s)
Date
2022-04Author
Kroschel, Ashleigh
Heinecke, Olivia
Gomes, Rahul
Metadata
Show full item recordAbstract
Pancreatic ductal adenocarcinoma (PDAC) is a deadly, invasive pancreatic cancer with 5-year survival for patients close to 7.1%. The difficulty of researching PDAC comes from a variety of factors that lead to its development, its genetic and epigenetic heterogeneity, the complicated tumor microenvironment, the human immune system’s role, and extensive fibrosis. Similarly, chromosomal alterations, ubiquitin proteases, and transcription factor alterations play a role in PDAC progression.
Subject
Pancreatic cancer
Genetically engineered mouse model
Cancer detection
Posters
Department of Computer Science
Permanent Link
http://digital.library.wisc.edu/1793/84599Type
Presentation
Description
Color poster with text, charts, and images.